InflaRx (IFRX) Enterprise Value (2017 - 2026)
InflaRx's (IFRX) quarterly Enterprise Value came in at -$22.3 million in Q2 2026, down 130.84% year-over-year from $72.4 million in Q2 2025, and down 225.76% quarter-over-quarter from $17.7 million in Q1 2026.
Analysis
InflaRx (IFRX) Enterprise Value (2017 - 2026) Analysis & Trends
InflaRx has disclosed Enterprise Value across 10 years of filings, most recently posting -$22.3 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 130.84% year-over-year to -$22.3 million; the TTM figure through Jun 2026 stood at -$22.3 million (down 130.84% YoY), while the FY2025 annual figure was $20.5 million, down 77.23% from the prior year.
- Enterprise Value came in at -$22.3 million for Q2 2026 at InflaRx, down from $17.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $268.6 million in Q2 2023 to a low of -$34.3 million in Q2 2022.
- Average Enterprise Value over 5 years is $40.9 million, with a median of $20.3 million recorded in 2024.
- Year-over-year, Enterprise Value surged 882.84% in 2023 and sank 1709.81% in 2025.
- Over 5 years, Enterprise Value stood at $36.3 million in 2022, then surged by 435.1% to $194.2 million in 2023, then tumbled by 53.59% to $90.1 million in 2024, then tumbled by 78.99% to $18.9 million in 2025, then tumbled by 217.84% to -$22.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$22.3 million in Q2 2026, $17.7 million in Q1 2026, and $18.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.32 Mn |
| Mar 31, 2026 | 17.74 Mn |
| Dec 31, 2025 | 18.94 Mn |
| Sep 30, 2025 | 27.34 Mn |
| Jun 30, 2025 | 72.37 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Dec 31, 2024 | 90.14 Mn |
| Sep 30, 2024 | 26.52 Mn |
| Jun 30, 2024 | 21.70 Mn |
| Mar 31, 2024 | -482,857.22 |
| Dec 31, 2023 | 194.20 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 268.59 Mn |
| Mar 31, 2023 | 17.09 Mn |
| Dec 31, 2022 | 36.29 Mn |
| Sep 30, 2022 | 22.31 Mn |
| Jun 30, 2022 | -34.31 Mn |
| Mar 31, 2022 | -20.14 Mn |
| Dec 31, 2021 | 291.94 Mn |
| Sep 30, 2021 | 38.38 Mn |